Harel Insurance Investments & Financial Services Ltd's Ownership in Teva Pharmaceutical Industries Ltd

Harel Insurance Investments & Financial Services Ltd has filed a Schedule 13G indicating its ownership of 58,118,222 ordinary shares of Teva Pharmaceutical Industries Ltd, representing 5.1% of the total outstanding shares. Of these, 56,881,124 shares are held for public members through various funds managed by subsidiaries, 114,084 shares are held in third-party client accounts managed by a subsidiary, and 1,123,014 shares are beneficially held for Harel's own account. The filing clarifies that Harel does not have sole voting or dispositive power over the majority of these shares, as they are managed independently by its subsidiaries. The filing also includes certifications that the shares were not acquired to influence the control of Teva.